The president said the consortium had already produced 100,000 rapid test kits and 100,000 PCR test kits.

The emergency ventilator, designed by teams from the Technology Assessment and Application Agency (BPPT), Bandung Institute of Technology (ITB), University of Indonesia (UI), Gajah Mada University, Dharma Group and Poly Jaya, is also ready for mass-production.

Other products ready for production or opening include a mobile BSL2 (biosafety level-2) lab, immunomodulatory products and artificial intelligent (AI) technology for detecting Covid-19.

Jokowi said aside from working together to fight Covid-19, Indonesia must also create an ecosystem that encourages innovations in science and technology.

"There's a new momentum for another national awakening. We have to continue improving science and technology in Indonesia, especially in the health sector," Jokowi said.

The president said the consortium's success would reduce the country's dependence on imported healthcare products.

Jokowi said the innovations must not stop at the laboratory or the prototype stage but must be able to be mass-produced to meet domestic demand at the very least.

"We have to meet domestic demand first and then we can think about exports," he said.

Jokowi said Indonesia must also be able to produce its own Covid-19 vaccine.

"I'm glad the research done by the Eijkman Institute of Molecular Biology has produced data on the seven genomes needed to develop a vaccine for Covid-19. It's been good to see the research community continuing with their hard work to find effective drugs and therapies for Covid-19," Jokowi said.

"We have to do more cooperation and collaboration. Research and development institutions, universities, businesses, industries and communities must all work together to overcome this outbreak," he said.